Literature DB >> 23549062

Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule.

Clarissa G Jakob1, Rohinton Edalji2, Russell A Judge1, Enrico DiGiammarino2, Yingchun Li3, Jijie Gu4, Tariq Ghayur4.   

Abstract

Several bispecific antibody-based formats have been developed over the past 25 years in an effort to produce a new generation of immunotherapeutics that target two or more disease mechanisms simultaneously. One such format, the dual-variable domain immunoglobulin (DVD-Ig™), combines the target binding domains of two monoclonal antibodies via flexible naturally occurring linkers, which yields a tetravalent IgG - like molecule. We report the structure of an interleukin (IL)12-IL18 DVD-Ig™ Fab (DFab) fragment with IL18 bound to the inner variable domain (VD) that reveals the remarkable flexibility of the DVD-Ig™ molecule and how the DVD-Ig™ format can function to bind four antigens simultaneously. An understanding of how the inner variable domain retains function is of critical importance for designing DVD-Ig™ molecules, and for better understanding of the flexibility of immunoglobulin variable domains and linkers, which may aid in the design of improved bi- and multi-specific biologics in general.

Entities:  

Keywords:  DFab; DVD-Ig™; Dual Specific Antibody; IL12; IL18

Mesh:

Substances:

Year:  2013        PMID: 23549062      PMCID: PMC4169029          DOI: 10.4161/mabs.23977

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  20 in total

1.  An approach to multi-copy search in molecular replacement.

Authors:  A Vagin; A Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-12

2.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

3.  Ligand association rates to the inner-variable-domain of a dual-variable-domain immunoglobulin are significantly impacted by linker design.

Authors:  Enrico L Digiammarino; John E Harlan; Karl A Walter; Uri S Ladror; Rohinton P Edalji; Charles W Hutchins; Marc R Lake; Amy J Greischar; Junjian Liu; Tariq Ghayur; Clarissa G Jakob
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

4.  Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

Authors:  Max S Topp; Peter Kufer; Nicola Gökbuget; Mariele Goebeler; Matthias Klinger; Svenja Neumann; Heinz-A Horst; Thorsten Raff; Andreas Viardot; Mathias Schmid; Matthias Stelljes; Markus Schaich; Evelyn Degenhard; Rudolf Köhne-Volland; Monika Brüggemann; Oliver Ottmann; Heike Pfeifer; Thomas Burmeister; Dirk Nagorsen; Margit Schmidt; Ralf Lutterbuese; Carsten Reinhardt; Patrick A Baeuerle; Michael Kneba; Hermann Einsele; Gert Riethmüller; Dieter Hoelzer; Gerhard Zugmaier; Ralf C Bargou
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

5.  Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target.

Authors:  Y Joy Yu; Yin Zhang; Margaret Kenrick; Kwame Hoyte; Wilman Luk; Yanmei Lu; Jasvinder Atwal; J Michael Elliott; Saileta Prabhu; Ryan J Watts; Mark S Dennis
Journal:  Sci Transl Med       Date:  2011-05-25       Impact factor: 17.956

6.  Bispecific digoxigenin-binding antibodies for targeted payload delivery.

Authors:  Silke Metz; Alexander K Haas; Karin Daub; Rebecca Croasdale; Jan Stracke; Wilma Lau; Guy Georges; Hans-Peter Josel; Sebastian Dziadek; Karl-Peter Hopfner; Alfred Lammens; Werner Scheuer; Eike Hoffmann; Olaf Mundigl; Ulrich Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin.

Authors:  Chengbin Wu; Hua Ying; Christine Grinnell; Shaughn Bryant; Renee Miller; Anca Clabbers; Sahana Bose; Donna McCarthy; Rong-Rong Zhu; Ling Santora; Rachel Davis-Taber; Yune Kunes; Emma Fung; Annette Schwartz; Paul Sakorafas; Jijie Gu; Edit Tarcsa; Anwar Murtaza; Tariq Ghayur
Journal:  Nat Biotechnol       Date:  2007-10-14       Impact factor: 54.908

9.  An overview of the CCP4 project in protein crystallography: an example of a collaborative project.

Authors:  M D Winn
Journal:  J Synchrotron Radiat       Date:  2002-12-24       Impact factor: 2.616

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  25 in total

1.  A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer.

Authors:  Weihua Hou; Qingyun Yuan; Xingxing Yuan; Yuxiong Wang; Wei Mo; Huijie Wang; Min Yu
Journal:  Invest New Drugs       Date:  2018-12-04       Impact factor: 3.850

2.  Fab-based bispecific antibody formats with robust biophysical properties and biological activity.

Authors:  Xiufeng Wu; Arlene J Sereno; Flora Huang; Steven M Lewis; Ricky L Lieu; Caroline Weldon; Carina Torres; Cody Fine; Micheal A Batt; Jonathan R Fitchett; Andrew L Glasebrook; Brian Kuhlman; Stephen J Demarest
Journal:  MAbs       Date:  2015       Impact factor: 5.857

3.  Engineering a high-affinity peptide binding site into the anti-CEA mAb M5A.

Authors:  Cindy Zer; Kendra N Avery; Kassondra Meyer; Leah Goodstein; Krzysztof P Bzymek; Gagandeep Singh; John C Williams
Journal:  Protein Eng Des Sel       Date:  2017-06-01       Impact factor: 1.650

4.  A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model.

Authors:  George Thom; Mei-Mei Tian; Jon P Hatcher; Natalia Rodrigo; Matthew Burrell; Ian Gurrell; Timothy Z Vitalis; Thomas Abraham; Wilfred A Jefferies; Carl I Webster; Reinhard Gabathuler
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-30       Impact factor: 6.200

5.  The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen.

Authors:  Ivan Correia; Joyce Sung; Randall Burton; Clarissa G Jakob; Bridget Carragher; Tariq Ghayur; Czeslaw Radziejewski
Journal:  MAbs       Date:  2013-04-09       Impact factor: 5.857

Review 6.  Bispecific antibodies in cancer immunotherapy.

Authors:  Siqi Chen; Jing Li; Qing Li; Zhong Wang
Journal:  Hum Vaccin Immunother       Date:  2016-06-01       Impact factor: 3.452

Review 7.  CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.

Authors:  Yaghoub Safdari; Vahideh Ahmadzadeh; Safar Farajnia
Journal:  Invest New Drugs       Date:  2016-04-13       Impact factor: 3.850

8.  CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications.

Authors:  Anke Steinmetz; François Vallée; Christian Beil; Christian Lange; Nicolas Baurin; Jochen Beninga; Cécile Capdevila; Carsten Corvey; Alain Dupuy; Paul Ferrari; Alexey Rak; Peter Wonerow; Jochen Kruip; Vincent Mikol; Ercole Rao
Journal:  MAbs       Date:  2016-03-16       Impact factor: 5.857

9.  Targeting Anti-TGF-β Therapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach.

Authors:  Steve McGaraughty; Rachel A Davis-Taber; Chang Z Zhu; Todd B Cole; Arthur L Nikkel; Meha Chhaya; Kelly J Doyle; Lauren M Olson; Gregory M Preston; Christine M Grinnell; Katherine M Salte; Anthony M Giamis; Yanping Luo; Victor Sun; Andrew D Goodearl; Murali Gopalakrishnan; Susan E Lacy
Journal:  J Am Soc Nephrol       Date:  2017-08-21       Impact factor: 10.121

10.  O-glycosylation of glycine-serine linkers in recombinant Fc-fusion proteins: attachment of glycosaminoglycans and other intermediates with phosphorylation at the xylose sugar subunit.

Authors:  Chris Spahr; Stone D-H Shi; Hsieng S Lu
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.